| Category : |
API |
| CAS No. : |
608141-41-9 |
| Synonyms : |
Apremilast Form B; Apremilast |
| Mol. Formula : |
C22H24N2O7S |
| Assay : |
98.0% to 102.0% on dried substance |
| Certificates and Documents : |
GMP/WC/DMF |
| Appearance : |
White to light yellow powder |
| Grade : |
Pharma Grade |
| Application : |
Apremilast is a non-steroidal medication used for the treatment of inflammatory conditions such as psoriasis and psoriatic arthritis. Apremilast, also known as Otezla, is a phosphodiesterase 4 (PDE4) inhibitor used to treat various types of symptoms resulting from certain inflammatory autoimmune diseases. |
| Packaging Details : |
15 Kg/ Drum |
| Delivery time : |
1-2 weeks |
| Storage : |
Sealed, protect from light |
| Shelf life : |
3 years |